PAR 3.92% 24.5¢ paradigm biopharmaceuticals limited..

In the video of PR added by Eire2021 on 4/02/2021 where PR talks...

  1. 55 Posts.
    lightbulb Created with Sketch. 9
    In the video of PR added by Eire2021 on 4/02/2021 where PR talks about the IND and the P3 trials starting in Q1 2021 and completing in Q1 2023, will we have to wait for all the results to be published in Q1 2023 or will the results be progressively published during the trial.
    If the results are successful then the progressive publishing of results during the trial may lead to a steady and reassuring rise in the share price which to me is better than having to wait until the end of the trial.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.010(3.92%)
Mkt cap ! $85.70M
Open High Low Value Volume
24.5¢ 25.0¢ 24.0¢ $59.66K 241.2K

Buyers (Bids)

No. Vol. Price($)
4 78837 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 36290 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.